We observed in this study that CDCA8 inhibition blocks AKT/GSK3β/β-catenin signaling in both parental HCC cell culture and CD133+ cell fraction (Figure 7A and Figure 8E). This evidence concerns the gene GSK3B and hepatocellular carcinoma.